$GSTX
Graphene & Solar Technologies Ltd

2023 Q2 Form 10-Q Financial Statement

#000190359623000717 Filed on September 13, 2023

View on sec.gov

Income Statement

Concept 2023 Q2
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $398.3K
YoY Change -10.51%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $80.00
YoY Change -99.97%
% of Gross Profit
Operating Expenses $398.3K
YoY Change -10.51%
Operating Profit -$398.3K
YoY Change
Interest Expense $5.375K
YoY Change 9.9%
% of Operating Profit
Other Income/Expense, Net $2.789K
YoY Change -216.35%
Pretax Income -$395.5K
YoY Change -10.65%
Income Tax
% Of Pretax Income
Net Earnings $395.5K
YoY Change -189.35%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 374.5M shares
Diluted Shares Outstanding 384.0M shares

Balance Sheet

Concept 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.500K
YoY Change 98.78%
Cash & Equivalents $6.495K
Short-Term Investments
Other Short-Term Assets $11.40K
YoY Change -37.53%
Inventory
Prepaid Expenses $11.40K
Receivables
Other Receivables
Total Short-Term Assets $17.90K
YoY Change -16.84%
LONG-TERM ASSETS
Property, Plant & Equipment $1.047K
YoY Change -33.27%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $6.038K
YoY Change -99.9%
TOTAL ASSETS
Total Short-Term Assets $17.90K
Total Long-Term Assets $6.038K
Total Assets $23.94K
YoY Change -99.61%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.551M
YoY Change 6.32%
Accrued Expenses $177.1K
YoY Change 3.28%
Deferred Revenue
YoY Change
Short-Term Debt $212.4K
YoY Change -15.62%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.778M
YoY Change 18.63%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.778M
Total Long-Term Liabilities $0.00
Total Liabilities $4.778M
YoY Change 18.63%
SHAREHOLDERS EQUITY
Retained Earnings -$67.84M
YoY Change 13.48%
Common Stock $3.854K
YoY Change 6.08%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$4.754M
YoY Change
Total Liabilities & Shareholders Equity $23.94K
YoY Change -99.61%

Cashflow Statement

Concept 2023 Q2
OPERATING ACTIVITIES
Net Income $395.5K
YoY Change -189.35%
Depreciation, Depletion And Amortization $80.00
YoY Change -99.97%
Cash From Operating Activities -$3.060K
YoY Change 774.29%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 9.800K
YoY Change
NET CHANGE
Cash From Operating Activities -3.060K
Cash From Investing Activities 0.000
Cash From Financing Activities 9.800K
Net Change In Cash 6.740K
YoY Change -2025.71%
FREE CASH FLOW
Cash From Operating Activities -$3.060K
Capital Expenditures $0.00
Free Cash Flow -$3.060K
YoY Change 774.29%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001497649
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q3 GSTX Intellectual Property At Cost
IntellectualPropertyAtCost
usd
CY2022Q3 us-gaap Other Loans Payable Current
OtherLoansPayableCurrent
usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q2 us-gaap Revenues
Revenues
usd
CY2022Q2 us-gaap Revenues
Revenues
usd
CY2022Q2 GSTX Loss On Extinguishment Of Debt
LossOnExtinguishmentOfDebt
usd
GSTX Loss On Extinguishment Of Debt
LossOnExtinguishmentOfDebt
usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
usd
GSTX Loss On Settlement Of Debt
LossOnSettlementOfDebt
usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
GSTX Cash Paid For Purchase Of Fixed Assets
CashPaidForPurchaseOfFixedAssets
usd
GSTX Cash Paid For Purchase Of Fixed Assets
CashPaidForPurchaseOfFixedAssets
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
usd
GSTX Issuance Of Short Term Note Payable
IssuanceOfShortTermNotePayable
usd
GSTX Issuance Of Short Term Note Payable
IssuanceOfShortTermNotePayable
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
GSTX Debt Discount
DebtDiscount
usd
CY2022Q3 us-gaap Other Loans Payable
OtherLoansPayable
usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Entity File Number
EntityFileNumber
333-174194
dei Entity Registrant Name
EntityRegistrantName
GRAPHENE & SOLAR TECHNOLOGIES LTD
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CO
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2888719
dei Entity Address Address Line1
EntityAddressAddressLine1
23 Corporate Plaza Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 150 
dei Entity Address City Or Town
EntityAddressCityOrTown
Newport Beach
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92660
dei City Area Code
CityAreaCode
(949)
dei Local Phone Number
LocalPhoneNumber
478-8387
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
384792610 shares
CY2023Q2 us-gaap Cash
Cash
6495 usd
CY2022Q3 us-gaap Cash
Cash
2857 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
11404 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
11183 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
17899 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
14040 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1047 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1273 usd
CY2023Q2 GSTX Intellectual Property At Cost
IntellectualPropertyAtCost
1 usd
CY2023Q2 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
975 usd
CY2022Q3 us-gaap Other Finite Lived Intangible Assets Gross
OtherFiniteLivedIntangibleAssetsGross
975 usd
CY2023Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
4015 usd
CY2022Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
2094 usd
CY2023Q2 us-gaap Assets
Assets
23937 usd
CY2022Q3 us-gaap Assets
Assets
18382 usd
CY2023Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
2550540 usd
CY2022Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
2380565 usd
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
177112 usd
CY2022Q3 us-gaap Interest Payable Current
InterestPayableCurrent
161602 usd
CY2023Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1838093 usd
CY2022Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1342405 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
60000 usd
CY2022Q3 us-gaap Notes Payable Current
NotesPayableCurrent
76255 usd
CY2023Q2 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
51694 usd
CY2022Q3 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
100747 usd
CY2023Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
100747 usd
CY2022Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
100747 usd
CY2023Q2 us-gaap Other Loans Payable Current
OtherLoansPayableCurrent
51694 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4778186 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4061574 usd
CY2023Q2 us-gaap Liabilities
Liabilities
4778186 usd
CY2022Q3 us-gaap Liabilities
Liabilities
4061574 usd
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
384237369 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
384237369 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
374305480 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
374305480 shares
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
3854 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
3748 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
63623368 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
63527513 usd
CY2023Q2 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
795000 usd
CY2022Q3 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
795000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-67841840 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-67070016 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-255369 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-290563 usd
CY2023Q2 GSTX Stockholders Equity2
StockholdersEquity2
4754249 usd
CY2022Q3 GSTX Stockholders Equity2
StockholdersEquity2
-4043192 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23937 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18382 usd
CY2023Q2 us-gaap Professional Fees
ProfessionalFees
322155 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
166256 usd
us-gaap Professional Fees
ProfessionalFees
610262 usd
us-gaap Professional Fees
ProfessionalFees
12892711 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
76099 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
278762 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
130737 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
829218 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
398254 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
445018 usd
us-gaap Operating Expenses
OperatingExpenses
740999 usd
us-gaap Operating Expenses
OperatingExpenses
13721929 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-398254 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-445018 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-740999 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-13721929 usd
CY2023Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
8116 usd
CY2022Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
7288 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
25078 usd
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
18564 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
5375 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
4891 usd
us-gaap Interest Expense
InterestExpense
15510 usd
us-gaap Interest Expense
InterestExpense
30319 usd
CY2023Q2 GSTX Loss On Extinguishment Of Debt
LossOnExtinguishmentOfDebt
-48 usd
GSTX Loss On Extinguishment Of Debt
LossOnExtinguishmentOfDebt
40393 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2789 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2397 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-30825 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11755 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
395465 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
442621 usd
us-gaap Net Income Loss
NetIncomeLoss
771824 usd
us-gaap Net Income Loss
NetIncomeLoss
13733684 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
22695 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
137979 usd
us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
-35194 usd
us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
81277 usd
CY2023Q2 GSTX Net Comprehensive Loss
NetComprehensiveLoss
-372770 usd
CY2022Q2 GSTX Net Comprehensive Loss
NetComprehensiveLoss
-304644 usd
GSTX Net Comprehensive Loss
NetComprehensiveLoss
-807018 usd
GSTX Net Comprehensive Loss
NetComprehensiveLoss
-13652409 usd
CY2023Q2 GSTX Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.00
CY2022Q2 GSTX Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.00
GSTX Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.00
GSTX Basic And Diluted Loss Per Common Share
BasicAndDilutedLossPerCommonShare
-0.04
CY2023Q2 GSTX Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
384009643 shares
CY2022Q2 GSTX Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
362823733 shares
GSTX Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
377541938 shares
GSTX Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
360954236 shares
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-4043192 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-74455 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-176458 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-4294105 usd
CY2023Q1 GSTX Settlement Of Notes1
SettlementOfNotes1
65211 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
16566 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-199901 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-4412229 usd
CY2023Q2 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
30750 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
22695 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-395465 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-4754249 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
3263621 usd
CY2021Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
46921 usd
CY2021Q4 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
12382500 usd
CY2021Q4 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-9246 usd
CY2021Q4 us-gaap Profit Loss
ProfitLoss
-12850758 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
2833038 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-47456 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
2345277 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
137979 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-442621 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
2040635 usd
us-gaap Profit Loss
ProfitLoss
-771824 usd
us-gaap Profit Loss
ProfitLoss
-13733684 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
30750 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
12382500 usd
us-gaap Depreciation
Depreciation
254 usd
us-gaap Depreciation
Depreciation
611 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
735096 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
13943 usd
GSTX Loss On Settlement Of Debt
LossOnSettlementOfDebt
40393 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
167158 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
225056 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
15510 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
17064 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-1921 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-2094 usd
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
472730 usd
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
312045 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-46950 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-49463 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
46921 usd
us-gaap Increase Decrease Due From Affiliates
IncreaseDecreaseDueFromAffiliates
51694 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
51694 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
46921 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1106 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2086 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
3638 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-456 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2857 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3728 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6495 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3272 usd
GSTX Debt Discount
DebtDiscount
24818 usd
GSTX Net Income Losses
NetIncomeLosses
67841838 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_844_eus-gaap--UseOfEstimates_zSvlY9PvAdV2" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86E_ztLwtqRjr4A8">Use of Estimates</span> - </i>The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant estimates include but are not limited to the estimated useful lives of equipment for purposes of depreciation and the valuation of common shares issued for services, equipment and the liquidation of liabilities.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0 0 6pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p>
CY2022Q3 us-gaap Notes Payable
NotesPayable
76255 usd
CY2023Q2 us-gaap Other Loans Payable
OtherLoansPayable
51694 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_849_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zwJrfTPPAI41" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_zpoqu5hridWg">Reclassifications</span> </i>- Certain amounts previously presented for prior periods have been reclassified to conform to the current presentation. The reclassifications had no effect on net loss, working capital or equity previously reported.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
100747 usd
CY2022Q3 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
100747 usd
CY2023Q2 us-gaap Notes Payable
NotesPayable
60000 usd
CY2023Q2 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
1 usd
CY2022Q2 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
6879745 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-837417 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6042328 usd

Files In Submission

Name View Source Status
0001903596-23-000717-index-headers.html Edgar Link pending
0001903596-23-000717-index.html Edgar Link pending
0001903596-23-000717.txt Edgar Link pending
0001903596-23-000717-xbrl.zip Edgar Link pending
ex31_1.htm Edgar Link pending
ex31_2.htm Edgar Link pending
ex32_1.htm Edgar Link pending
ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gstx-20230630.xsd Edgar Link pending
gstx_10q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
gstx-20230630_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
gstx-20230630_pre.xml Edgar Link unprocessable
gstx-20230630_cal.xml Edgar Link unprocessable
gstx-20230630_lab.xml Edgar Link unprocessable
gstx_10q_htm.xml Edgar Link completed
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending